Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults

Abstract Background When two or more vaccines are administered concurrently, there is concern about safety and immunogenicity from vaccine interaction. Methods Subjects aged ≥50 years were randomized 1:1:1 to receive tetanus-diphtheria (Td) + 13-valent pneumococcal conjugate vaccine (PCV13; Group 1)...

Full description

Bibliographic Details
Main Authors: Joon Young Song, Hee Jin Cheong, Ji Yun Noh, Min Joo Choi, Jin Gu Yoon, Saem Na Lee, Seong Hui Kang, Eun Joo Jeong, Yu Mi Jo, Woo Joo Kim
Format: Article
Published: BMC 2018-12-01
Series:BMC Infectious Diseases
Online Access: